Euro-Med Laboratories Phil., Inc.

EURO

PHY2352T1098

Pharmaceuticals

End-of-day quote Philippines S.E. Other stock markets 18:00:00 2024-05-12 EDT			5-day change	1st Jan Change
0.74 ^PHP	-5.13%		-3.90%	-1.33%

05-13	Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-15	Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Euro-Med Laboratories Phil., Inc. Appoints Mr. Anthony Joseph Y. Gaw as Director

June 16, 2021 at 12:44 am

Euro-Med Laboratories Phil., Inc. announced that at its AGM held on June 16, 2021, shareholders approved the appointment of Mr. Anthony Joseph Y. Gaw as director. Mr. Anthony Joseph Y. Gaw also appointed as audit and risk oversight committee member.

Latest news about Euro-Med Laboratories Phil., Inc.

Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-14	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-18	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-13	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-14	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-10	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Euro-Med Laboratories Phil., Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Euro-Med Laboratories Phil., Inc. Appoints Mr. Anthony Joseph Y. Gaw as Director	21-06-16	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
Euro-Med Laboratories Phil., Inc. Announces Demise of Atty. Francis Y. Gaw, Member of the Board of Directors	21-04-22	CI
Euro-Med Laboratories Phil., Inc. Announces Resignation of Michael Vincent Y. Yap as Vice President	21-03-30	CI
Euro-Med Laboratories Phil., Inc. Elects Mr. Enrique Y. Yap, Jr. as Director	20-08-18	CI
Euro-Med Laboratories Phil., Inc. Provides Earnings Guidance for the Year 2020	20-06-30	CI
Euro-Med Laboratories Phil., Inc. Announces Parent Earnings Results for the First Quarter Ended March 31, 2020	20-06-30	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-06-28	CI
Euro-Med Laboratories Phil., Inc. Approves Resignation of Michael Vincent Y. Yap as Director and Assistant Corporate Secretary and Retirement of Rnold D. Ong as Senior Vice President	19-11-26	CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-13	CI
Euro-Med Laboratories Phil., Inc. Announces Management Appointments	19-06-19	CI
Euro-Med Laboratories Phil., Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2019	19-05-06	CI
Euro-Med Laboratories Phil., Inc. Announces Consolidated Earnings Results for the Year Ended December 31, 2018	19-04-15	CI

Chart Euro-Med Laboratories Phil., Inc.

Duration

Period

More charts

Company Profile

Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.

Sector

Pharmaceuticals

Calendar

2024-06-18 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
EURO-MED LABORATORIES PHIL., INC.	-1.33%	52.64M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22.62%	43.81B
OTSUKA HOLDINGS CO., LTD.	+25.56%	23.01B
SANDOZ GROUP AG	+18.81%	15.27B
CIPLA LIMITED	+9.91%	13.68B
ZYDUS LIFESCIENCES LIMITED	+42.40%	11.96B
ONO PHARMACEUTICAL CO., LTD.	-7.49%	6.98B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.26%	5.59B

Generic Pharmaceuticals